Croda International Plc (LON:CRDA – Get Free Report) insider Stephen Oxley bought 4 shares of the stock in a transaction that occurred on Tuesday, November 10th. The shares were purchased at an average cost of GBX 3,625 per share, with a total value of £145.
Stephen Oxley also recently made the following trade(s):
- On Monday, October 12th, Stephen Oxley bought 5 shares of Croda International stock. The stock was purchased at an average price of GBX 3,388 per share, for a total transaction of £169.40.
- On Thursday, September 10th, Stephen Oxley purchased 4 shares of Croda International stock. The shares were purchased at an average cost of GBX 3,218 per share, for a total transaction of £128.72.
Croda International Stock Performance
Shares of CRDA opened at GBX 3,687 on Wednesday. The company has a current ratio of 2.57, a quick ratio of 2.25 and a debt-to-equity ratio of 36.06. The stock has a market capitalization of £5.14 billion, a P/E ratio of 64.80, a price-to-earnings-growth ratio of 1.40 and a beta of 0.92. The firm’s fifty day simple moving average is GBX 3,418.85 and its two-hundred day simple moving average is GBX 3,086.67. Croda International Plc has a 12 month low of GBX 2,488 and a 12 month high of GBX 3,784.
Analyst Ratings Changes
A number of research analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a GBX 3,300 price objective on shares of Croda International in a research note on Friday, November 6th. Citigroup raised their target price on Croda International from GBX 3,050 to GBX 3,200 and gave the stock a “neutral” rating in a research note on Wednesday, July 29th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 4,000 target price on shares of Croda International in a research note on Thursday, November 5th. Finally, Berenberg Bank lifted their target price on Croda International from GBX 3,600 to GBX 4,400 and gave the stock a “buy” rating in a report on Friday, November 6th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 3,650.
Check Out Our Latest Stock Report on CRDA
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Recommended Stories
- Five stocks we like better than Croda International
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
